Enabling personalized medicine: Getting the framework right?

Tuesday 15th of April 2014
SY32, 1.5 hours

Chair: Wolfgang Sadee (USA)

Meeting room 211

10.30 – 11.00 Improving drug safety through personalised medicine approaches
(TU-14-01) Munir Pirmohammed, University of Liverpool, UK

11.00 – 11.30 Developing evidence to inform the clinical utillity and cost-effectiveness of pharmacogenomic markers: Challenges and opportunities
(TU-14-02) Michael Sorich, Flinders University, Adelaide, Australia

11.30 – 12.00 Personalised medicine and therapeutic drug monitoring – adding value to current practice
(TU-14-03) Niels Vande Casteele, KU Leuven, Leuven, Belgium and University of California San Diego, La Jolla, USA